Organon Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Organon Stock Summary

Organon competes with Johnson Johnson, Bristol Myers, AbbVie, Eli Lilly, and Pfizer. Organon Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Organon Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon CO operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 9300 people.

Organon Key Financial Ratios

Organon Key Balance Sheet Accounts

Organon Key Income Statement Accounts

Organon Key Cash Accounts

Organon Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Organon's current stock value. Our valuation model uses many indicators to compare Organon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organon competition to find correlations between indicators driving Organon's intrinsic value. More Info.Organon Co is regarded fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.17  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Organon Co is roughly  5.82 . At this time, Organon's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organon's earnings, one of the primary drivers of an investment's value.

Organon's Earnings Breakdown by Geography

Organon Systematic Risk

Today, most investors in Organon Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Organon's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Organon growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Organon help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Organon Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Organon Co based on widely used predictive technical indicators. In general, we focus on analyzing Organon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Organon's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.